United Lincolnshire Hospitals NHS Trust - Pligrim Hospital Boston

The United Lincolnshire Hospitals NHS Trust - Pilgrim Hospital Boston incorporates Pilgrim Hospital in Boston https://www.ulh.nhs.uk/
Chemotherapy toxicity data presented at trust level because 94% of data was coded at trust level.

In 2015, United Lincolnshire Hospitals NHS Trust split into United Lincolnshire Hospitals NHS Trust - Lincoln and Grantham and United Lincolnshire Hospitals NHS Trust - Pilgrim Hospital Boston.

View previous outcomes

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site PET-CT facilities
    • On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
    • Routine Genetic Testing for Lynch Syndrome
  • Surgical services:
    • Robotic surgery

Data Quality

All Patients: Trust Network National
Number of patients in Audit 186 2258 35779
Case ascertainment (%) Good Good Good
Data completeness of:
– Pre-treatment TNM (%) 86 79 86
– Performance status (%) 97 92 89
Patients having major resection: Trust Network National
Number of patients in Audit 104 1187 19631
ASA grade 1 (%) N/A 8 9
ASA grade 2 (%) 48 52 53
ASA grade 3 (%) 51 30 31
ASA grade 4+ (%) 1 2 2
ASA grade not recorded (%) N/A 8 4
Data completeness of:
7 Audit items for risk-adjustment (%) 99 89 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients

All Patients: Trust Network National
Number of patients in Audit 186 2258 35779
Seen by Clinical Nurse Specialist (%) 93 94 88

Management of patients having major resection

Patients having major resection: Trust Network National
Number of patients in Audit 104 1187 19614
Distant metastases (%) 5 5 5
Urgent or emergency surgery (%) 18 14 15
At least 12 lymph nodes excised (%) 91 85 84
Laparoscopic surgery attempted (%) 78 71 72
Risk-adjusted length of stay > 5 days (%) 46 56 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 70 N/A 10747
Adjuvant chemotherapy (%) 71 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 65 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 31 N/A 22

Rectal cancer patients

Patients having major resection: Trust Network National
Number of patients in Audit 19 N/A 4251
Neoadjuvant therapy (%) 62 N/A 33
Circumferential resection margin: Recorded (%) 95 94 89
Circumferential resection margin: Negative (%) 95 88 83
Rectal volume 19 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 65 1284 19644
APER/Hartmanns (%) 45 43 37

Compare trust outcomes